Creative Medical (CELZ) Fundamental Analysis: Revenue, Earnings & Valuation

4.57 / 10

Netural

Fundamental score is 4.57. Strong points include Asset‑MV, Revenue‑MV and Cash‑MV with positive Q values, while Gross profit margin and Cost of sales are weak. YoY revenue fell 45%, and tax ratio is zero, indicating moderate but uneven fundamentals.

Analysis Checks(7/10)

Revenue-MV

Value-6.28

Score2/3

Weight32.29%

1M Return8.45%

Total operating revenue (YoY growth rate %)

Value-45.45

Score3/3

Weight5.13%

1M Return1.54%

Inventory turnover ratio

Value2.00

Score2/3

Weight-3.70%

1M Return-1.21%

Gross profit margin (%)

Value63.43

Score0/3

Weight-19.26%

1M Return-7.24%

PB-ROE

Value-0.43

Score1/3

Weight22.05%

1M Return5.29%

Income tax / Total profit (%)

Value0.00

Score1/3

Weight-1.52%

1M Return-0.50%

Fixed assets turnover ratio

Value9306.28

Score3/3

Weight3.39%

1M Return1.06%

Cost of sales ratio (%)

Value36.57

Score2/3

Weight-12.64%

1M Return-4.42%

Asset-MV

Value-0.55

Score2/3

Weight50.89%

1M Return12.22%

Cash-MV

Value0.02

Score2/3

Weight23.38%

1M Return5.94%

Is CELZ fundamentally strong?

CELZ scores 4.57/10 on fundamentals and holds a Fair valuation at present. Backed by its -86.47% ROE, -99916.80% net margin, -1.24 P/E ratio, 0.99 P/B ratio, and 32.08% earnings growth, these metrics solidify its Netural investment rating.